JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A5078 KU-0063794

Target: mTOR

Summary: MTORC1 and mTORC2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.65 mg/mL
A8214 AZD8055
2 Citation

Target: mTOR

Summary: MTOR inhibitor

≥23.3 mg/mL
A8312 Torin 1
7 Citation

Target: mTOR

Summary: MTOR inhibitor,potent and selective
A8318 PP242

Target: mTOR

Summary: MTOR inhibitor, selective and ATP-competitive
A8551 INK 128 (MLN0128)
4 Citation

Target: mTOR

Summary: MTOR(TORC-1/-2) inhibitor,potent and selective

insoluble in H2O; ≥15.45 mg/mL
A8556 GSK2126458
1 Citation

Target: PI3K|mTOR

Summary: PI3K/mTOR inhibitor

≥25.3 mg/mL
A8764 Rapalink-1

Target: mTOR

Summary: third-generation mTOR inhibitor

≥178.4 mg/mL
B5853 MHY1485
2 Citation

Target: mTOR

Summary: mTOR activator, autophage inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.35 mg/mL
B1639 Ridaforolimus (Deforolimus, MK-8669)

Target: mTOR

Summary: MTOR inhibitor

≥49.5 mg/mL
B1641 WAY-600

Target: mTOR

Summary: MTOR inhibitor

≥12.38 mg/mL